Select Page


Adamis Pharmaceuticals Corporation is a biopharmaceutical company engaged in the development and commercialization of specialty pharmaceutical products in the therapeutic areas of respiratory disease and allergy. Our goal is to lay the foundation to become one of the leading biopharmaceutical companies in our focus area. We are attempting to accomplish this by focusing our efforts on producing products that help treat life-threatening diseases, help patients attain a better quality of life, and at the same time, create substantial shareholder value.